Long-term safety Research status : Limited long-term human studies (newer peptides) Available data : Animal studies show excellent safety Human case reports very positive No known serious adverse effects Mitochondrial support theoretically beneficial Precautionary approach : Start with lower doses Monitor how you feel Consider periodic breaks Track health markers Contraindications Avoid if : Pregnancy or breastfeeding (no safety data) Active cancer (theoretical mitochondrial support to cancer cells) Severe cardiovascular disease (consult doctor) Consult doctor if : Chronic health conditions Taking multiple medications Mitochondrial disorders (ironically, may need medical supervision) Monitoring Recommended blood work : Baseline metabolic panel Glucose/HbA1c (if using for metabolic health) Liver/kidney function Retest at 12 weeks Frequency : Every 3-6 months during long-term use Biomarkers to track : Fasting glucose Insulin sensitivity markers Inflammatory markers (hs-CRP) Energy levels (subjective) Sourcing quality NAD+ peptides Quality critical for effectiveness and safety
From these three inputs, the calculator does one calculation twice: Concentration (mg/mL) = Vial content (mg) Diluent volume (mL) Injection volume (mL or units) = Target dose (mg) Concentration (mg/mL) A Worked Example Say a research vial contains 10mg of retatrutide, reconstituted with 2mL of bacteriostatic water
This represents preliminary evidence only
In the United States, patients usually receive vitamin B 12 injections of 1 mg/d in their first week of treatment
Alternative Therapies in Health and Medicine , vol
Standard dosing approach The most commonly cited dosing range is 50 to 150mg per day, typically divided into one to three doses
